Investor Relations

We are a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Our FDA-approved proprietary RxSight Light Adjustable Lens system consists of our Light Adjustable Lens™ (LAL® / LAL+™), Light Delivery Device (LDD™) and accessories. It is the first and only commercially available intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. With the RxSight system, doctors perform a standard cataract procedure to implant the LAL, determine refractive error with patient input after healing is complete, then use the LDD to reshape the Light Adjustable Lens with the exact amount of visual correction needed to achieve the patients’ desired vision outcomes.